Autonomix

Autonomix, Inc. is a medical device development company focused on advancing innovative technologies to revolutionize the diagnosis and treatment of diseases involving the peripheral nervous system. The company’s top-tier technology platform includes a catheter-based microchip sensor array capable of detecting and distinguishing peripheral nerve signals with a sensitivity 1,000 times greater than existing technologies. We believe this will enable, for the first time ever, the diagnosis and treatment of peripheral nervous system disorders in nearly any part of the body through blood vessels. Autonomix's technology was initially developed for pancreatic cancer and pancreatitis, two conditions that cause debilitating pain and require an effective solution. However, our technology serves as a platform with the potential to address dozens of conditions, spanning a wide range of disease categories including cardiology, renal denervation, and chronic pain management.